Antibiotic Options for Otitis Media with Sulfa and Azithromycin Allergies

Primary Treatment Options

The American Academy of Pediatrics recommends using an oral cephalosporin, such as cefdinir, cefuroxime axetil, or cefpodoxime proxetil, as first-line therapy for patients with otitis media who are allergic to both sulfa drugs and azithromycin, with a clinical efficacy of 83-88% 1, 2
The American Academy of Pediatrics suggests that cephalosporins can be safely used in patients with non-severe penicillin allergies, as cross-reactivity occurs in only 0.1% of cases when severe/recent reactions are excluded 1
Cefdinir is often preferred based on patient acceptance and compliance, with excellent coverage against the primary otitis media pathogens: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 3, 5

The American Academy of Pediatrics recommends clindamycin as the first-line alternative for patients with a Type I (immediate) hypersensitivity to penicillin, with a clinical efficacy of 90-92% 2
Clindamycin resistance among relevant pathogens is only 1% in the United States, but it has no activity against H. influenzae or M. catarrhalis 1, 5, 6

The American Academy of Pediatrics suggests switching to intramuscular ceftriaxone 50 mg/kg daily for 3-5 days if oral cephalosporins fail, with a clinical efficacy of 90-92% for respiratory fluoroquinolones, but these should be reserved for multidrug-resistant cases after consultation with infectious disease specialists 1, 2, 5